Yhdysvallat - englanti - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. calcium acetate capsule contains calcium acetate and is excreted in human milk. human milk feeding by a mother receiving calcium acetate is not expected to harm an infant, provided maternal serum calcium levels are appropriately monitored. safety and effectiveness in pediatric patients have not been established. clinical studies of calcium acetate did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other clinical experience has not identified differences in responses between elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Yhdysvallat - englanti - NLM (National Library of Medicine)

kaiser foundation hospitals - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg

Yhdysvallat - englanti - NLM (National Library of Medicine)

cardinal health - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg

Yhdysvallat - englanti - NLM (National Library of Medicine)

nephro-tech, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg

Yhdysvallat - englanti - NLM (National Library of Medicine)

apex energetics inc. - abies alba leafy twig (unii: ce3g3j56lr) (abies alba leafy twig - unii:ce3g3j56lr), calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb), calcium hypophosphite (unii: cui83r2732) (calcium cation - unii:2m83c4r6zb), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), calcium oxalate monohydrate (unii: 4pp86kk527) (calcium cation - unii:2m83c4r6zb), tribasic calcium phosphate (unii: 91d9gv0z28) (phosphate ion - unii:nk08v8k8hr), calcium picrate (unii: 53d441qvt8) (calcium picrate - unii:53d441qvt8), calendula officinalis flowering top (unii: 18e7415pxq) (calendula officinalis flowering top - unii:18e7415pxq), calcium hexafluorosilicate (unii: 2nvp93xvq3) (calcium hexafluorosilicate - unii:2nvp93xvq3), sulfur iodide (unii: l6l8ka2aa0) (sulfur iodide - unii:l6l8ka2aa0), bos taurus gallstone (unii: 4162lz0n4o) (bos taurus gallstone - unii:4162lz0n4o), urtica urens (unii: ihn2nq5of9) (urtica urens - unii:ihn2nq5of9), vitamin d (unii: 9vu1ki44gp) (vitamin d - unii:9vu1ki44gp), cholesterol (unii: 97c5t2uq7j) (cholesterol - unii:97c5t2uq7j), calcium sulfide (unii: 1mbw07j51q) (calcium sulfide - unii:1mbw07j51q), calcium arsenate (unii: 95ox15i8zu) (arsenate ion - unii:g1dbi405ok), calcium iodide (unii: 8eki9qee2h) (calcium cation - unii:2m83c4r6zb), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), hamamelis virginiana root bark/stem bark (unii: t7s323pkjs) (hamamelis virginiana root bark/stem bark - unii:t7s323pkjs), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), sus scrofa parathyroid gland (unii: 2kbe35ne8s) (sus scrofa parathyroid gland - unii:2kbe35ne8s), comfrey root (unii: m9vvz08ekq) (comfrey root - unii:m9vvz08ekq), calcium sulfate anhydrous (unii: e934b3v59h) (calcium cation - unii:2m83c4r6zb) - for temporary relief of minor: spasms* cramps* nervous irritability* menstrual discomfort* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Yhdysvallat - englanti - NLM (National Library of Medicine)

state of florida doh central pharmacy - calcium acetate (unii: y882yxf34x) (calcium - unii:sy7q814vup) - calcium acetate capsules are indicated for the control of hyperphosphatemia in end stage renal failure and do not promote aluminum absorption. patients with hypercalcemia.

Yhdysvallat - englanti - NLM (National Library of Medicine)

international medication systems, limited - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb) - calcium chloride 100 mg in 1 ml - 10% calcium chloride injection, usp is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. calcium chloride is contraindicated for cardiac resuscitation in the presence of ventricular fibrillation or in patients with the risk of existing digitalis toxicity.    calcium chloride is not recommended in the treatment of asystole and electromechanical dissociation. none known.

Yhdysvallat - englanti - NLM (National Library of Medicine)

vitality works, inc. - chrysopogon zizanioides root (unii: 37tb8lup9z) (chrysopogon zizanioides root - unii:37tb8lup9z), barium iodide (unii: wkc4t7680a) (barium cation - unii:v645272hln), calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb), calendula officinalis flowering top (unii: 18e7415pxq) (calendula officinalis flowering top - unii:18e7415pxq), gallic acid monohydrate (unii: 48339473ot) (gallic acid - unii:632xd903sp), gamboge (unii: 7556hj7587) (gamboge - unii:7556hj7587), hyoscyamus niger (unii: 4 - chrysopogon zizanioides root 10 [hp_x] in 1 ml

Yhdysvallat - englanti - NLM (National Library of Medicine)

acella pharmaceuticals, llc - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), boron (unii: n9e3x5056q) (boron - unii:n9e3x5056q), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - calcium carbonate 1342 mg - indications and usage: calcium-folic acid plus d chewable wafers are indicated, in addition to diet, to help satisfy the distinctive nutritional requirements of individuals under the supervision of a physician for the treatment of calcium deficiency, skeletal weakness and osteoporosis. calcium-folic acid plus d chewable wafers supplementation may be beneficial to individuals who have an insufficient dietary intake of the nutrients contained therein. calcium and vitamin d supplementation may be useful in both preventing and treating osteoporosis. vitamin d supplementation may be beneficial to those who are institutionalized and/or have reduced exposure to sunlight. folic acid, vitamin b 6 , and vitamin b 12 , may help reduce the risk of cardiovascular disease by lowering blood levels of homocysteine. if dietary intake of calcium is inadequate, patients currently taking bisphosphonates for treatment of osteoporosis should be instructed to take calcium and vitamin d daily (calcium-folic

Yhdysvallat - englanti - NLM (National Library of Medicine)

general injectables & vaccines, inc - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - calcium chloride 100 mg in 1 ml - 10% calcium chloride injection, usp is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. calcium chloride is contraindicated for cardiac resuscitation in the presence of ventricular fibrillation or in patients with the risk of existing digitalis toxicity. calcium chloride is not recommended in the treatment of asystole and electromechanical dissociation. none known.